OpenEvidence
PrivateLast Round
Series D
Jan 21, 2026
Est. Valuation
$12B
Total Funding Raised
$735M
Momentum Score
50 /100
Company Overview
OpenEvidence is a healthcare technology company that offers an AI-driven information platform designed to organize and enhance the accessibility of global medical knowledge for improved decision-making and patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Vertical SaaS, NLP & Conversational AI
Business Model
B2B2C
Customer Profile
Freemium, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OpenEvidence Comps
Public and private peers based on sector, stage, and business model.
OpenEvidence Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 21, 2026 | ||||
| Series C | Oct 20, 2025 | ||||
| Series B | Jul 15, 2025 | ||||
| Series A | Feb 19, 2025 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
BID | |||||
BID |
Key People
Founding team and executive leadership
OpenEvidence Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series D |
| DST Global | Series D |
| Blackstone | Series C, Series D |
| GV | Series D, Series C, Series B |
| Craft Ventures | Series C, Series D |
| Thrive Capital | Series C, Series B, Series D |
| Sequoia Capital | Series C, Series B, Series D, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2026
Open job postings increased from 0 to 11 roles.
- Apr 8, 2026
Collaborating with The New England Journal of Medicine.
OpenEvidence Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OpenEvidence's valuation, stock price, and market status.
